Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 819 shares (grant or award)
  2. 4 Grant or award Director acquired 1,265 shares (grant or award)
  3. 4 Grant or award Director acquired 1,150 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise Director acquired 1,424 shares (option exercise)
  9. 4 Grant or award Director acquired 1,372 shares (grant or award)
  10. 4 Grant or award Director acquired 1,246 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4/A Shares withheld for taxes Chief Legal Officer gave up 1,102 shares (to pay taxes)
  17. 4/A Shares withheld for taxes President & CEO gave up 3,675 shares (to pay taxes)
  18. 4/A Shares withheld for taxes Chief Scientific Officer gave up 1,102 shares (to pay taxes)
  19. 4/A Shares withheld for taxes Chief Financial Officer gave up 1,102 shares (to pay taxes)
  20. 4/A Shares withheld for taxes Chief People Officer gave up 1,102 shares (to pay taxes)

Page 9 of 15 · 296 filings